新西兰在工作场所使用甲基安非他明的情况正在急剧增加,影响到全国20%以上的药物测试。 Workplace methamphetamine use in New Zealand is surging, affecting over 20% of drug tests nationwide.

新西兰的工作场所甲基安非他明使用率正在上升,20%以上的与毒品有关的工作场所检测呈阳性,仅3月份就达到近25%。 Workplace methamphetamine use in New Zealand is rising, with over 20% of drug-related workplace tests coming back positive, and nearly 25% in March alone. 这个问题超出了大城市的范围,影响到中北部和塔拉纳基等较小的地区。 The issue spans beyond major cities, affecting smaller regions like the Central North and Taranaki. 毒品检测局敦促雇主重新评估其政策,对任何怀疑迅速采取行动,以确保工作场所的安全和生产力。 The Drug Detection Agency (TDDA) urges employers to reassess their policies and act swiftly on any suspicions to ensure workplace safety and productivity.